Rosetta Omics
PrivateLast Round
Pre Seed
May 1, 2024
Total Funding Raised
$375,000
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Rosetta Omics is a biotechnology company that develops an AI-enabled spatial and multiomics platform to predict treatment response in solid tumors from a single tissue slide.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rosetta Omics Comparables
Compare Rosetta Omics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Navignostics AG | 81% | |
| StratifAI GmbH | 79% | |
| Tempus | 73% |
Rosetta Omics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 1, 2024 |
Key People
Founding team and executive leadership
Rosetta Omics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Pre Seed |
| 165 Global | Pre Seed |
| Bpifrance | Pre Seed |
| Saudi Biotechnology Accelerator | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Dec 25, 2025
Grew 25% QoQ, from 12 to 15 employees.
Rosetta Omics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rosetta Omics's valuation, stock price, and market status.
Is Rosetta Omics a public or private company?
Rosetta Omics is a private company.
What is the current stock price of Rosetta Omics?
Rosetta Omics is a private company with no public stock price. No recent secondary market data is available.
How much is Rosetta Omics worth (valuation)?
Valuation information for Rosetta Omics is not publicly available.
Can I buy Rosetta Omics stock?
Rosetta Omics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rosetta Omics's last funding round?
Rosetta Omics's most recent funding round was Pre Seed on May 1, 2024.
Who are the main investors in Rosetta Omics?
Key investors in Rosetta Omics include Agoranov, Bpifrance, 165 Global, Saudi Biotechnology Accelerator.
Will Rosetta Omics IPO soon?
No public IPO plans have been announced for Rosetta Omics.
How can I track Rosetta Omics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rosetta Omics's secondary market activity and sign up for updates.